Management considerations for childhood-onset systemic lupus erythematosus patients and implications on therapy

References

• Malattia C, Martini A. Paediatric-onset systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2013;27(3):351–362.
   PubMed Web of Science ®Google Scholar
• Silva CA, Avcin T, Brunner HI. Taxonomy for systemic lupus erythematosus with onset before adulthood. Arthritis Care Res (Hoboken). 2012;64(12):1787–1793.
   PubMed Web of Science ®Google Scholar
• Klumb EM, Silva CA, Lanna CC, et al. Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis. Rev Bras Reumatol. 2015;55(1):1–21.
   PubMed Web of Science ®Google Scholar
• Mina R, Brunner HI. Update on differences between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Res Ther. 2013;15(4):218.
   PubMed Web of Science ®Google Scholar
• Ardoin SP, Schanberg LE. Paediatric rheumatic disease: lessons from SLE: children are not little adults. Nat Rev Rheumatol. 2012;8(8):444–445.
   PubMed Web of Science ®Google Scholar
• Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–2686.
   PubMed Web of Science ®Google Scholar
• Sag E, Tartaglione A, Batu ED, et al. Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicentre study. Clin Exp Rheumatol. 2014;32(3):440–444.
   PubMed Web of Science ®Google Scholar
• Fonseca AR, Gaspar-Elsas MI, Land MG, et al. Comparison between three systems of classification criteria in juvenile systemic lupus erythematous. Rheumatology (Oxford). 2015;54(2):241–247.
   PubMed Web of Science ®Google Scholar
• Brunner HI, Huggins J, Klein-Gitelman MS. Pediatric SLE-towards a comprehensive management plan. Nat Rev Rheumatol. 2011;7(4):225–233.
   PubMed Web of Science ®Google Scholar
• Midgley A, Watson L, Beresford MW. New insights into the pathogenesis and management of lupus in children. Arch Dis Child. 2014;99(6):563–567.
   PubMed Web of Science ®Google Scholar
• Moorthy LN, Peterson MG, Baratelli M, et al., International SMILEY Collaborative Group. Preliminary cross-cultural adaptation of a new pediatric health-related quality of life scale in children with systemic lupus erythematosus: an international effort. Lupus. 2010;19(1):83–88.
   PubMed Web of Science ®Google Scholar
• Moorthy LN, Roy E, Kurra V, et al. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: an international collaboration. Pediatr Rheumatol Online J. 2014;12:49.
   PubMed Web of Science ®Google Scholar
• Jones JT, Cunningham N, Kashikar-Zuck S, et al. Pain, fatigue and psychological impact on health-related quality of life in childhood-onset lupus. Arthritis Care Res (Hoboken). 2015. DOI:10.1002/acr.22650.
   Web of Science ®Google Scholar
• Ruperto N, Pistorio A, Ravelli A, et al. Criteria to define response to therapy in paediatric rheumatic diseases. Eur J Clin Pharmacol. 2011;67(Suppl 1):125–131.
   PubMed Web of Science ®Google Scholar
• Mina R, Klein-Gitelman MS, Nelson S, et al. Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus. Ann Rheum Dis. 2014;73(2):401–406.
   PubMed Web of Science ®Google Scholar
• Mina R, Klein-Gitelman MS, Ravelli A, et al. Inactive disease and remission in childhood-onset systemic lupus erythematosus. Arthritis are Res (Hoboken). 2012;64(5):683–693.
   PubMed Web of Science ®Google Scholar
• Bennett M, Brunner HI. Biomarkers and updates on pediatrics lupus nephritis. Rheum Dis Clin North Am. 2013;39(4):833–853.
   PubMed Web of Science ®Google Scholar
• Abulaban KM, Brunner HI. Biomarkers for childhood-onset systemic lupus erythematosus. Curr Rheumatol Rep. 2015;17(1):471.
   PubMed Web of Science ®Google Scholar
• Hinze CH, Suzuki M, Klein-Gitelman M, et al. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum. 2009;60(9):2772–2781.
   PubMed Web of Science ®Google Scholar
• Watson L, Tullus K, Pilkington C, et al. Urine biomarkers for monitoring juvenile lupus nephritis: a prospective longitudinal study. Pediatr Nephrol. 2014;29(3):397–405.
   PubMed Web of Science ®Google Scholar
• Hollander MC, Sage JM, Greenler AJ, et al. International consensus for provisions of quality-driven care in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2013;65(9):1416–1423.
   PubMed Web of Science ®Google Scholar
• Mina R, Harris JG, Klein-Gitelman MS, et al. Initial benchmarking of the quality of medical care of childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2015. DOI:10.1002/acr.22666.
   Web of Science ®Google Scholar
• Arıcı ZS, Batu ED, Ozen S. Reviewing the recommendations for lupus in children. Curr Rheumatol Rep. 2015;17(3):174.
   Web of Science ®Google Scholar
• Barsalou J, Levy DM, Silverman ED. An update on childhood-onset systemic lupus erythematosus. Curr Opin Rheumatol. 2013;25(5):616–622.
   PubMed Web of Science ®Google Scholar
• Faco MM, Leone C, Campos LM, et al. Risk factors associated with the death of patients hospitalized for juvenile systemic lupus erythematosus. Braz J Med Biol Res. 2007;40(7):993–1002.
   PubMed Web of Science ®Google Scholar
• Sinha R, Raut S. Pediatric lupus nephritis: management update. World J Nephrol. 2014;3:16–23.
   PubMedGoogle Scholar
• Mina R, Von Scheven E, Ardoin SP, et al., et al. Consensus treatment plans for induction therapy of newly risk factors associated with the death of patients hospitalized for juvenile systemic lupus erythematosus diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012;64(3):375–383.
   PubMed Web of Science ®Google Scholar
• van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis. 2014;73(6):958–967.
   PubMed Web of Science ®Google Scholar
• Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771–1782.
   PubMed Web of Science ®Google Scholar
• Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012;64(6):797–808.
   PubMed Web of Science ®Google Scholar
• Sundel R, Solomons N, Lisk L, Aspreva Lupus Management Study (ALMS) Group. Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial. Lupus. 2012;21:131433–1443.
   PubMed Web of Science ®Google Scholar
• Susantitaphong P, Sewaralthahab K, Balk EM, et al. Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis. Am J Hypertens. 2013;26(3):424–441.
   PubMed Web of Science ®Google Scholar
• Tambralli A, Beukelman T, Cron RQ, et al. Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases. J Rheumatol. 2015;42(3):541–546.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Watanabe S, Aizawa-Yashiro T, et al. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice. Nephron Clin Pract. 2012;121(3–4):c165–73.
   PubMedGoogle Scholar
• Tian SY, Feldman BM, Beyene J, et al. Immunosuppressive therapies for the induction treatment of proliferative lupus nephritis: a systematic review and network metaanalysis. J Rheumatol. 2014;41(10):1998–2007.
   PubMed Web of Science ®Google Scholar
• Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010;69(12):2074–2082.
   PubMed Web of Science ®Google Scholar
• Carneiro JR, Sato EI. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus. J Rheumatol. 1999;26(6):1275–1279.
   PubMed Web of Science ®Google Scholar
• Gormezano NW, Silva CA, Otsuzi CI, et al. Higher prevalence and distinct features of herpes zoster infection in children than adults with systemic lupus erythematosus. Pediatr Infect Dis J. 2015;34(8):905–907.
   PubMed Web of Science ®Google Scholar
• Silva MF, Ribeiro AS, Fiorot FJ, et al. Invasive aspergillosis: a severe infection in juvenile systemic lupus erythematosus patients. Lupus. 2012;21(9):1011–1016.
   PubMed Web of Science ®Google Scholar
• Silva MF, Ferriani MP, Terreri MT, et al. A multicenter study of invasive fungal infections survey in 852 childhood-onset systemic lupus erythematosus patients. J Rheumatol. 2015 Nov 15. pii: jrheum.150142. [Epub ahead of print].
   Web of Science ®Google Scholar
• Lee PP, Lee TL, Ho MH, et al. Recurrent major infections in juvenile-onset systemic lupus erythematosus–a close link with long-term disease damage. Rheumatology (Oxford). 2007;46(8):1290–1296.
   PubMed Web of Science ®Google Scholar
• Al-Mayouf SM, Al-Jumaah S, Bahabri S, et al. Infections associated with juvenile systemic lupus erythematosus. Clin Exp Rheumatol. 2001;19(6):748–750.
   PubMed Web of Science ®Google Scholar
• Costa-Reis P, Nativ S, Isgro J, et al. Major infections in a cohort of 120 patients with juvenile-onset systemic lupus erythematosus. Clin Immunol. 2013;149(3):442–449.
   PubMed Web of Science ®Google Scholar
• Guariento A, Silva MF, Tassetano PS, et al. Liver and spleen biometrics in childhood-onset systemic lupus erythematosus patients. Rev Bras Reumatol. 2015;55(4):346–351.
   PubMed Web of Science ®Google Scholar
• Jesus AA, Liphaus BL, Silva CA, et al. Complement and antibody primary immunodeficiency in juvenile systemic lupus erythematosus patients. Lupus. 2011;20(12):1275–1284.
   PubMed Web of Science ®Google Scholar
• Lube G, Aikawa NE, Tacla M, et al. Condyloma acuminatum by human papilloma virus infection in childhood-systemic lupus erythematosus patients. Acta Reumatol Port. 2014;39(2):182–187.
   PubMed Web of Science ®Google Scholar
• Freire PS, Montoni JD, Ribeiro AS, et al. Miliary tuberculosis: a severe opportunistic infection in juvenile systemic lupus erythematosus patients. Rev Bras Reumatol. 2014 Oct 14. pii: S0482-5004(14)00180-6. doi: 10.1016/j.rbr.2014.04.007. [Epub ahead of print].
   Web of Science ®Google Scholar
• Yilmaz N, Zehra Aydin S, Inanc N, et al. Comparison of QuantiFERON-TB gold test and tuberculin skin test for the identification of latent mycobacterium tuberculosis infection in lupus patients. Lupus. 2012;21:491–495.
   PubMed Web of Science ®Google Scholar
• Silva CA, Terreri MT, Aikawa NE, et al. Vaccination practice in children with rheumatic disease. Rev Bras Reumatol. 2010;50(4):351–361.
   PubMed Web of Science ®Google Scholar
• Silva CA, Aikawa NE, Bonfa E. Vaccinations in juvenile chronic inflammatory diseases: an update. Nat Rev Rheumatol. 2013;9(9):532–543.
   PubMed Web of Science ®Google Scholar
• Barbosa CM, Terreri MT, Rosário PO, et al. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus. Clin Exp Rheumatol. 2012;30(5):791–798.
   PubMed Web of Science ®Google Scholar
• Campos LM, Silva CA, Aikawa NE, et al. High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2013;65:1121–1127.
   PubMed Web of Science ®Google Scholar
• Aikawa NE, Trudes G, Campos LM, et al. Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients. Lupus. 2013;22(13):1394–1398.
   PubMed Web of Science ®Google Scholar
• Grimaldi-Bensouda L, Guillemot D, Godeau B, et al. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. J Intern Med. 2014;275(4):398–408.
   PubMed Web of Science ®Google Scholar
• Mok CC, Ho LY, Fong LS, et al. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study. Ann Rheum Dis. 2013;72(5):659–664.
   PubMed Web of Science ®Google Scholar
• Ostensen M, Brucato A, Carp H, et al. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford). 2011;50(4):657–664.
   PubMed Web of Science ®Google Scholar
• Silva CA, Bonfa E, Østensen M. Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs. Arthritis Care Res (Hoboken). 2010 Dec;62(12):1682–1690.
   PubMed Web of Science ®Google Scholar
• Silva CA, Yamakami LY, Aikawa NE, et al. Autoimmune primary ovarian insufficiency. Autoimmun Rev. 2014;13(4–5):427–430.
   PubMed Web of Science ®Google Scholar
• Silva CA, Cocuzza M, Borba EF, et al. Cutting-edge issues in autoimmune orchitis. Clin Rev Allergy Immunol. 2012;42(2):256–263.
   PubMed Web of Science ®Google Scholar
• Silva CA, Cocuzza M, Carvalho JF, et al. Diagnosis and classification of autoimmune orchitis. Autoimmun Rev. 2014;13(4–5):431–434.
   PubMed Web of Science ®Google Scholar
• Aikawa NE, Sallum AM, Pereira RM, et al. Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy. Clin Exp Rheumatol. 2012;30(3):445–449.
   PubMed Web of Science ®Google Scholar
• De Araujo DB, Yamakami LY, Aikawa NE, et al. Ovarian reserve in adult patients with childhood-onset lupus: a possible deleterious effect of methotrexate? Scand J Rheumatol. 2014;43(6):503–511.
   PubMed Web of Science ®Google Scholar
• Soares PM, Borba E, Bonfa E, et al. Gonad evaluation in male systemic lupus erythematosus. Arthritis Rheum. 2007;56(7):2352–2361.
   PubMed Web of Science ®Google Scholar
• Suehiro RM, Borba EF, Bonfa E, et al. Testicular Sertoli cell function in male systemic lupus erythematosus. Rheumatology (Oxford). 2008;47(11):1692–1697.
   PubMed Web of Science ®Google Scholar
• Vecchi AP, Borba EF, Bonfá E, et al. Penile anthropometry in systemic lupus erythematosus patients. Lupus. 2011;20(5):512–518.
   PubMed Web of Science ®Google Scholar
• Brunner HI, Silva CA, Reiff A, et al. Randomized, double-blind, dose-escalation trial of triptorelin for ovary protection in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol. 2015;67(5):1377–1385.
   PubMed Web of Science ®Google Scholar
• Silva CA, Hilario MO, Febronio MV, et al. Pregnancy outcome in juvenile systemic lupus erythematosus: a Brazilian multicenter cohort study. J Rheumatol. 2008;35(7):1414–1418.
   PubMed Web of Science ®Google Scholar
• Araujo DB, Borba EF, Abdo CH, et al. Sexual function in rheumatic diseases. Acta Reumatol Port. 2010;35(1):16–23.
   PubMed Web of Science ®Google Scholar
• Yen S, Martin S. Contraception for adolescents. Pediatr Ann. 2013;42(2):21–25.
   PubMed Web of Science ®Google Scholar
• Sammaritano LR. Contraception in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lupus. 2014;23(12):1242–1245.
   PubMed Web of Science ®Google Scholar
• Ardoin SP, Schanberg LE, Sandborg C, et al. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. Lupus. 2010;19(11):1315–1325.
   PubMed Web of Science ®Google Scholar
• De Carvalho JF, Bonfá E, Borba EF. Systemic lupus erythematosus and “lupus dyslipoproteinemia”. Autoimmun Rev. 2008;7(3):246–250.
   PubMed Web of Science ®Google Scholar
• Schanberg LE, Sandborg C, Barnhart HX, et al. Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Arthritis Rheum. 2012;64(1):285–296.
   PubMed Web of Science ®Google Scholar
• Ardoin SP, Schanberg LE, Sandborg CI, et al. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ann Rheum Dis. 2014;73(3):557–566.
   PubMed Web of Science ®Google Scholar
• Gualano B, Sá Pinto AL, Perondi B, et al. Evidence for prescribing exercise as treatment in pediatric rheumatic diseases. Autoimmun Rev. 2010;9(8):569–573.
   PubMed Web of Science ®Google Scholar
• Gualano B, Pinto AL, Perondi MB, et al. Therapeutic effects of exercise training in patients with pediatric rheumatic diseases. Rev Bras Reumatol. 2011;51(5):490–496.
   PubMed Web of Science ®Google Scholar
• Prado DM, Gualano B, Pinto AL, et al. Exercise in a child with systemic lupus erythematosus and antiphospholipid syndrome. Med Sci Sports Exerc. 2011;43(12):2221–2223.
   PubMed Web of Science ®Google Scholar
• Prado DM, Benatti FB, de Sá-Pinto AL, et al. Exercise training in childhood-onset systemic lupus erythematosus: a controlled randomized trial. Arthritis Res Ther. 2013;15(2):R46.
   PubMed Web of Science ®Google Scholar
• Hayashi AP, Solis MY, Sapienza MT, et al. Efficacy and safety of creatine supplementation in childhood-onset systemic lupus erythematosus: a randomized, double-blind, placebo-controlled, crossover trial. Lupus. 2014;23(14):1500–1511.
   PubMed Web of Science ®Google Scholar
• Jesus AA, Jacob CM, Silva CA, et al. Common variable immunodeficiency associated with hepatosplenic T-cell lymphoma mimicking juvenile systemic lupus erythematosus. Clin Dev Immunol. 2011;2011:428703.
   PubMed Web of Science ®Google Scholar
• Goobie GC, Bernatsky S, Ramsey-Goldman R, et al. Malignancies in systemic lupus erythematosus: a 2015 update. Curr Opin Rheumatol. 2015;27(5):454–460.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Clarke AE, Labrecque J, et al. Cancer risk in childhood-onset systemic lupus. Arthritis Res Ther. 2013;15(6):R198.
   PubMed Web of Science ®Google Scholar
• Stagi S, Cavalli L, Bertini F, et al. Cross-sectional and longitudinal evaluation of bone mass and quality in children and young adults with juvenile onset systemic lupus erythematosus (JSLE): role of bone mass determinants analyzed by DXA, PQCT and QUS. Lupus. 2014;23(1):57–68.
   PubMed Web of Science ®Google Scholar
• Casella CB, Seguro LP, Takayama L, et al. Juvenile onset systemic lupus erythematosus: a possible role for vitamin D in disease status and bone health. Lupus. 2012;21(12):1335–1342.
   PubMed Web of Science ®Google Scholar
• Von Scheven E, Corbin KJ, Stagi S, et al. Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment. Curr Osteoporos Rep. 2014;12(3):289–299.
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The J Clin Endocrinol Metab. 2011;96(7):1911–1930.
   PubMed Web of Science ®Google Scholar
• Pereira RM, Carvalho JF, Canalis E. Glucocorticoid-induced osteoporosis in rheumatic diseases. Clinics (Sao Paulo). 2010;65(11):1197–1205.
   PubMed Web of Science ®Google Scholar
• Pereira RM, Carvalho JF, Paula AP, et al. Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis. Rev Bras Reumatol. 2012;52(4):580–593.
   PubMed Web of Science ®Google Scholar
• Peracchi OA, Terreri MT, Munekata RV, et al. Low serum concentrations of 25-hydroxyvitamin D in children and adolescents with systemic lupus erythematosus. Braz J Med Biol Res. 2014;47(8):721–726.
   PubMed Web of Science ®Google Scholar
• Lima GL, Paupitz J, Aikawa NE, et al. A randomized double-blind placebo-controlled trial of vitamin D supplementation in adolescents and young adults with juvenile-onset SLE: improvement in disease activity and fatigue scores. Arthritis Care Res (Hoboken). 2015 (in press). DOI:10.1002/acr.22621.
   PubMed Web of Science ®Google Scholar
• Robinson AB, Tangpricha V, Yow E, et al. Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy. Lupus Sci Med. 2014;1(1):e000037.
   Google Scholar
• Robinson AB, Tangpricha V, Yow E, et al. Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy. Lupus Sci Med. 2014;1(1):e000011.
   Google Scholar
• Aggarwal A, Srivastava P. Childhood onset systemic lupus erythematosus: how is it different from adult SLE? Int J Rheum Dis. 2015;18(2):182–191.
   PubMed Web of Science ®Google Scholar
• McGrady ME, Hommel KA. Medication adherence and health care utilization in pediatric chronic illness: a systematic review. Pediatrics. 2013;132(4):730–740.
   PubMed Web of Science ®Google Scholar
• Ting TV, Kudalkar D, Nelson S, et al. Usefulness of cellular text messaging for improving adherence among adolescents and young adults with systemic lupus erythematosus. J Rheumatol. 2012;39(1):174–179.
   PubMed Web of Science ®Google Scholar
• Sagcal-Gironella AC, Sherwin CM, Tirona RG, et al. Pharmacokinetics of prednisolone at steady state in young patients with systemic lupus erythematosus on prednisone therapy: an open-label, single-dose study. Clin Ther. 2011;33(10):1524–1536.
   PubMed Web of Science ®Google Scholar
• Sherwin CM, Sagcal-Gironella AC, Fukuda T, et al. Development of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood-onset systemic lupus erythematosus. Br J Clin Pharmacol. 2012;73(5):727–740.
   PubMed Web of Science ®Google Scholar
• Fukuda T, Brunner HI, Sagcal-Gironella AC, et al. Nonsteroidal anti-inflammatory drugs may reduce enterohepatic recirculation of mycophenolic acid in patients with childhood-onset systemic lupus erythematosus. Ther Drug Monit. 2011;33(5):658–662.
   PubMed Web of Science ®Google Scholar
• Zelko F, Beebe D, Baker A, et al. Academic outcomes in childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012;64(8):1167–1174.
   PubMed Web of Science ®Google Scholar
• Felsenstein S, Reiff AO, Ramanathan A. Transition of care and health-related outcomes in pediatric onset systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2015 (in press). DOI:10.1002/acr.22611.
   PubMed Web of Science ®Google Scholar
• Watson L, Leone V, Pilkington C, et al. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. Arthritis Rheum. 2012;64(7):2356–2365.
   PubMed Web of Science ®Google Scholar
• Lim LS, Lefebvre A, Benseler S, et al. Long term outcomes and damage accrual in patients with childhood systemic lupus erythematosus with psychosis and severe cognitive dysfunction. J Rheumatol. 2013;40(4):513–519.
   PubMed Web of Science ®Google Scholar
• Salah S, Lotfy HM, Mokbel AN, et al. Damage index in childhood-onset systemic lupus erythematosus in Egypt. Pediatr Rheumatol Online J. 2011;9(1):36.
   PubMed Web of Science ®Google Scholar